MENU

Replimune Group (REPL) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

REPL is expected to report earnings to rise 4.48% to -85 cents per share on August 01

Replimune Group REPL Stock Earnings Reports
Q2'24
Est.
$-0.86
Q1'24
Missed
by $0.05
Q4'23
Beat
by $0.12
Q3'23
Missed
by $0.09
Q2'23
Beat
by $0.05
The last earnings report on May 16 showed earnings per share of -81 cents, missing the estimate of -76 cents. With 67.77K shares outstanding, the current market capitalization sits at 700.29M.
View a ticker or compare two or three
REPL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Unicorn Park Drive
Phone
+1 781 222-9600
Employees
284
Web
https://www.replimune.com